1. Home
  2. Author
  3. Niedergethmann M

Niedergethmann M

References (2)

Title : Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities - Hirmas_2023_J.Nucl.Med_64_711
Author(s) : Hirmas N , Hamacher R , Sraieb M , Ingenwerth M , Kessler L , Pabst KM , Barbato F , Lueckerath K , Kasper S , Nader M , Schildhaus HU , Kesch C , von Tresckow B , Hanoun C , Hautzel H , Aigner C , Glas M , Stuschke M , Kummel S , Harter P , Lugnier C , Uhl W , Niedergethmann M , Hadaschik B , Grunwald V , Siveke JT , Herrmann K , Fendler WP
Ref : J Nucl Med , 64 :711 , 2023
Abstract :
PubMedSearch : Hirmas_2023_J.Nucl.Med_64_711
PubMedID: 36581374

Title : (68)Ga-Labeled Fibroblast Activation Protein Inhibitor ((68)Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the (68)Ga-FAPI PET Observational Trial - Kessler_2023_J.Nucl.Med_64_1910
Author(s) : Kessler L , Hirmas N , Pabst KM , Hamacher R , Ferdinandus J , Schaarschmidt BM , Milosevic A , Nader M , Umutlu L , Uhl W , Reinacher-Schick A , Lugnier C , Witte D , Niedergethmann M , Herrmann K , Fendler WP , Siveke JT
Ref : J Nucl Med , 64 :1910 , 2023
Abstract :
PubMedSearch : Kessler_2023_J.Nucl.Med_64_1910
PubMedID: 37973185